克林顿健康发展组织：2005-2024年美国总统疟疾倡议（PMI）疟疾防控活动影响评估报告（英文版

From 2005-2024, across 25 partner countries, on average PMI’s greatest proportional contribution to increases in intervention coverage was to artemisinin combination therapy (ACT, 32.7%) followed by indoor residual spraying (IRS, 43.3%), insecticide treated bed-nets (ITNs, 18.0%), and seasonal chemoprevention (SMC, 11.4%).